acetylglucosamine has been researched along with Cross Infection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Datta, R; Ericsson, M; Gadjeva, M; Goldmann, DA; Grout, M; Huang, SS; Lee, JC; Maira-Litran, T; Merighi, M; Pier, GB; Skurnik, D | 1 |
| Cerca, N; Ceri, H; Gomes, F; Oliveira, R; Teixeira, P | 1 |
| Adley, CC; Pembroke, JT; Ryan, MP | 1 |
3 other study(ies) available for acetylglucosamine and Cross Infection
| Article | Year |
|---|---|
Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.
Topics: Acetylglucosamine; Animals; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Bacteremia; Cross Infection; Female; Humans; Mice; Opsonin Proteins; Staphylococcal Infections; Staphylococcus aureus | 2010 |
Virulence gene expression by Staphylococcus epidermidis biofilm cells exposed to antibiotics.
Topics: Acetylglucosamine; Amidohydrolases; Anti-Bacterial Agents; Biofilms; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Gene Expression Regulation, Bacterial; Gentamicins; Humans; Phosphoric Monoester Hydrolases; Polysaccharides, Bacterial; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Virulence | 2011 |
Differentiating the growing nosocomial infectious threats Ralstonia pickettii and Ralstonia insidiosa.
Topics: Acetylglucosamine; Anti-Bacterial Agents; Arabinose; Bacterial Typing Techniques; Cross Infection; Deferoxamine; Gram-Negative Bacterial Infections; Humans; Nitrates; Oxidation-Reduction; Phenylacetates; Ralstonia | 2011 |